Joseph P. Gerdt

Joseph P. Gerdt

Auto-generated profile, based on publicly available information

Joseph P. Gerdt

Department of Chemistry, Indiana University Bloomington, Bloomington, Indiana, USA.

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in Cell
Verified
Journal Article
Open access
NBNicolas M.B. Brancucci
Nicolas M.B. Brancucci
JGJoseph P. Gerdt
Joseph P. Gerdt
CWChengQi Wang
ChengQi Wang
MNMariana De Niz
Mariana De Niz
NPNisha Philip
Nisha Philip
MMMatthias Marti
Matthias Marti
Transmission represents a population bottleneck in the Plasmodium life cycle and a key intervention target of ongoing efforts to eradicate malaria. Sexual differentiation is essential for this process, as only sexual parasites, called gametocytes, are infective to the mosquito vector. Gametocyte production rates vary depending on environmental conditions, but external stimuli remain obscure. Here, we show that the host-derived lipid lysophosphatidylcholine (LysoPC) controls P. falciparum cell fate by repressing parasite sexual differentiation. We demonstrate that exogenous LysoPC drives biosynthesis of the essential membrane component phosphatidylcholine. LysoPC restriction induces a compensatory response, linking parasite metabolism to the activation of sexual-stage-specific transcription and gametocyte formation. Our results reveal that malaria parasites can sense and process host-derived physiological signals to regulate differentiation. These data close a critical knowledge gap in parasite biology and introduce a major component of the sexual differentiation pathway in Plasmodium that may provide new approaches for blocking malaria transmission.

1 September 2017 in Cell
Verified
Journal Article
Closed access
AWArielle Woznica
Arielle Woznica
JGJoseph P. Gerdt
Joseph P. Gerdt
RHRyan E. Hulett
Ryan E. Hulett
JCJon Clardy
Jon Clardy
NKNicole King
Nicole King

8 August 2014 in ACS Chemical Biology
Verified
Journal Article
Open access
JGJoseph P. Gerdt
Joseph P. Gerdt
HBHelen E. Blackwell
Helen E. Blackwell
The growing threat of antibiotic resistance necessitates the development of novel antimicrobial therapies. Antivirulence agents that target group-beneficial traits in microorganisms (i.e., phenotypes that help the cells surrounding the producer cell instead of selfishly benefiting only the producer cell) represent a new antimicrobial approach that may be robust against the spread of resistant mutants. One prominent group-beneficial antivirulence target in bacteria is quorum sensing (QS). While scientists are producing new QS inhibitors (QSIs) at an increasing pace for use as research tools and potential therapeutic leads, substantial work remains in empirically demonstrating a robustness against resistance. Herein we report the results of in vitro competition studies in Pseudomonas aeruginosa that explicitly confirm that two separate barriers can impede the spread of resistance to QSIs: (1) insufficient native QS signal levels prevent rare QSI-resistant bacteria from expressing their QS regulon, and (2) group-beneficial QS-regulated phenotypes produced by resistant bacteria are susceptible to cheating by QSI-sensitive neighbors, even when grown on a solid substrate with limited mixing to mimic infected tissue. These results underscore the promise of QSIs and other antivirulence molecules that target group beneficial traits as resistance-robust antimicrobial treatments and provide support for their further development.

29 January 2014 in ChemBioChem
Verified
Journal Article
Closed access
PDF file
JMJoseph D. Moore
Joseph D. Moore
JGJoseph P. Gerdt
Joseph P. Gerdt
NENora R. Eibergen
Nora R. Eibergen
HBHelen E. Blackwell
Helen E. Blackwell

9 February 2023 in Nature Microbiology
Verified
Journal Article
Open access
PDF file
QZQ. Zhang
Q. Zhang
VLV. Linke
V. Linke
KOK. A. Overmyer
K. A. Overmyer
LTL. L. Traeger
L. L. Traeger
KKK. Kasahara
K. Kasahara
FRF. E. Rey
F. E. Rey
The molecular bases of how host genetic variation impacts the gut microbiome remain largely unknown. Here we used a genetically diverse mouse population and applied systems genetics strategies to identify interactions between host and microbe phenotypes including microbial functions, using faecal metagenomics, small intestinal transcripts and caecal lipids that influence microbe–host dynamics. Quantitative trait locus (QTL) mapping identified murine genomic regions associated with variations in bacterial taxa; bacterial functions including motility, sporulation and lipopolysaccharide production and levels of bacterial- and host-derived lipids. We found overlapping QTL for the abundance of Akkermansia muciniphila and caecal levels of ornithine lipids. Follow-up in vitro and in vivo studies revealed that A. muciniphila is a major source of these lipids in the gut, provided evidence that ornithine lipids have immunomodulatory effects and identified intestinal transcripts co-regulated with these traits including Atf3, which encodes for a transcription factor that plays vital roles in modulating metabolism and immunity. Collectively, these results suggest that ornithine lipids are potentially important for A. muciniphila–host interactions and support the role of host genetics as a determinant of responses to gut microbes.

1 October 2014 in Chemistry & Biology
Verified
Journal Article
Closed access
JGJoseph P. Gerdt
Joseph P. Gerdt
CMChristine E. McInnis
Christine E. McInnis
TSTrevor L. Schell
Trevor L. Schell
FRFrancis M. Rossi
Francis M. Rossi
HBHelen E. Blackwell
Helen E. Blackwell